semaglutide 4mg vial Sem-P Injection 4mg/3ml Photo Illustration of the new

The risk and type of side effects are often similar, but some users might find side effects more bothersome with one medicine over the other

Meta-analyses and systematic reviews report that MI alone or combined with DCI in a 40:1 ratio may help support ovulation frequency, menstrual regularity, insulin sensitivity, and some hormone-related markers in people with PCOS.1 2 3 31 That said, responses vary, and improvements tend to be gradual rather than dramatic.17 People seeking fertility or egg-quality support Inositol has been studied in fertility and assisted reproductive settings, where it appears to support oocyte maturation and ovarian responsiveness particularly in people with PCOS or insulin-related reproductive dysfunction.27 28 45 Some studies report improvements in egg quality and fertilization outcomes with consistent use, though evidence is strongest in PCOS populations and more limited in people without underlying metabolic or hormonal concerns.17 Pregnant individuals at risk for gestational diabetes Several clinical trials and meta-analyses suggest that myo-inositol supplementation during pregnancy may reduce the risk of gestational diabetes in people who are already considered higher risk.9 24 25 26 45 Because pregnancy is a unique physiological state, decisions about inositol supplementation during pregnancy should be made with guidance from a healthcare professional familiar with your medical history

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights including MC1R rs1805008 to provide a comprehensive view of how your genetics may influence these interconnected systems

Novartis supported the expansion application with topline data from the Phase III NATALEE trial, in which treatment with Kisqali led to a significant improvement in disease-free survival versus standard adjuvant endocrine therapy alone, according to the company

Prices for GLP-1 medications range from $230 for semaglutide to $390 for the more potent tirzepatide, with each dose potentially lasting 8 to 12 weeks